Sudan Loganathan's Stock Ratings

Stephens & Co. Analyst

Sudan Loganathan is an analyst at Stephens & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/18/2025

Updated: Dec 18, 2025

Overall Average Return

12.9%

Smart Score

65.6%

Overall Average Return Percentile

64th

Number of Ratings

52
Buy NowGet Alert
12/17/2025APGEBuy Now
Apogee Therapeutics
$75.5025.83% → $95Initiates → OverweightGet Alert
12/11/2025KYMRBuy Now
Kymera Therapeutics
$82.0734.03%$65 → $110MaintainsOverweightGet Alert
12/08/2025CADLBuy Now
Candel Therapeutics
$5.46174.73%$15 → $15ReiteratesOverweight → OverweightGet Alert
11/24/2025PYXSBuy Now
Pyxis Oncology
$3.35138.81%$5 → $8MaintainsOverweightGet Alert
11/17/2025IMNMBuy Now
Immunome
$20.0264.85%$25 → $33MaintainsOverweightGet Alert
11/10/2025ARVNBuy Now
Arvinas
$11.9525.52%$14 → $15MaintainsOverweightGet Alert
11/05/2025DCTHBuy Now
Delcath Systems
$9.9680.72%$25 → $18MaintainsOverweightGet Alert
10/28/2025CADLBuy Now
Candel Therapeutics
$5.46174.73% → $15Initiates → OverweightGet Alert
10/28/2025CNTABuy Now
Centessa Pharmaceuticals
$24.9840.11% → $35Initiates → OverweightGet Alert
09/22/2025CCCCBuy Now
C4 Therapeutics
$2.11184.36%$6 → $6ReiteratesOverweight → OverweightGet Alert
09/18/2025ARVNBuy Now
Arvinas
$11.9517.15%$16 → $14MaintainsOverweightGet Alert
09/15/2025CCCCBuy Now
C4 Therapeutics
$2.11184.36%$3 → $6UpgradeEqual-Weight → OverweightGet Alert
09/09/2025IDYABuy Now
IDEAYA Biosciences
$33.7333.41%$45 → $45ReiteratesOverweight → OverweightGet Alert
07/10/2025NRIXBuy Now
Nurix Therapeutics
$18.5461.81%$30 → $30ReiteratesOverweight → OverweightGet Alert
06/24/2025EXELBuy Now
Exelixis
$41.9842.94%$29 → $60UpgradeEqual-Weight → OverweightGet Alert
06/23/2025DCTHBuy Now
Delcath Systems
$9.96151%$25 → $25ReiteratesOverweight → OverweightGet Alert
06/03/2025BPMCBuy Now
Blueprint Medicines
$150 → $135DowngradeOverweight → Equal-WeightGet Alert
03/24/2025ELEVBuy Now
Elevation Oncology
$5 → $1DowngradeOverweight → Equal-WeightGet Alert
03/20/2025IMNMBuy Now
Immunome
$20.0249.86%$30 → $30ReiteratesOverweight → OverweightGet Alert
03/07/2025ELEVBuy Now
Elevation Oncology
$5 → $5ReiteratesOverweight → OverweightGet Alert
02/27/2025CPRXBuy Now
Catalyst Pharmaceuticals
$24.0137.44%$33 → $33ReiteratesOverweight → OverweightGet Alert
02/24/2025ADCTBuy Now
ADC Therapeutics
$3.74113.9%$6 → $8MaintainsOverweightGet Alert
02/14/2025IDYABuy Now
IDEAYA Biosciences
$33.7348.24%$50 → $50ReiteratesOverweight → OverweightGet Alert
02/12/2025EXELBuy Now
Exelixis
$41.98-30.91%$29 → $29ReiteratesEqual-Weight → Equal-WeightGet Alert
01/27/2025EXELBuy Now
Exelixis
$41.98-30.91%$29 → $29ReiteratesEqual-Weight → Equal-WeightGet Alert
01/22/2025BCYCBuy Now
Bicycle Therapeutics
$6.95115.83%$15 → $15ReiteratesEqual-Weight → Equal-WeightGet Alert
01/21/2025NRIXBuy Now
Nurix Therapeutics
$18.5467.21%$31 → $31ReiteratesOverweight → OverweightGet Alert
01/21/2025KYMRBuy Now
Kymera Therapeutics
$82.07-26.89%$60 → $60ReiteratesOverweight → OverweightGet Alert
01/02/2025BPMCBuy Now
Blueprint Medicines
$140 → $140ReiteratesOverweight → OverweightGet Alert
12/06/2024ELEVBuy Now
Elevation Oncology
$5 → $5ReiteratesOverweight → OverweightGet Alert
11/19/2024ATNMBuy Now
Actinium Pharma
$1.60212.5%$5 → $5ReiteratesOverweight → OverweightGet Alert
11/18/2024CPRXBuy Now
Catalyst Pharmaceuticals
$24.0145.77% → $35Initiates → OverweightGet Alert
11/18/2024IDYABuy Now
IDEAYA Biosciences
$33.7351.2% → $51Initiates → OverweightGet Alert
11/18/2024CCCCBuy Now
C4 Therapeutics
$2.1189.57% → $4Initiates → Equal-WeightGet Alert
11/18/2024KYMRBuy Now
Kymera Therapeutics
$82.07-20.8% → $65Initiates → OverweightGet Alert
11/18/2024ARVNBuy Now
Arvinas
$11.95360.25% → $55Initiates → OverweightGet Alert
11/08/2024BCYCBuy Now
Bicycle Therapeutics
$6.95259.71% → $25Initiates → Equal-WeightGet Alert
11/08/2024ADCTBuy Now
ADC Therapeutics
$3.7460.43% → $6Initiates → OverweightGet Alert
11/08/2024IMNMBuy Now
Immunome
$20.0249.86% → $30Initiates → OverweightGet Alert
11/08/2024PYXSBuy Now
Pyxis Oncology
$3.35288.06% → $13Initiates → OverweightGet Alert
10/30/2024EXELBuy Now
Exelixis
$41.98-30.91%$23 → $29MaintainsEqual-WeightGet Alert
10/14/2024NRIXBuy Now
Nurix Therapeutics
$18.5467.21%$31 → $31ReiteratesOverweight → OverweightGet Alert
08/06/2024DCTHBuy Now
Delcath Systems
$9.96151%$25 → $25ReiteratesOverweight → OverweightGet Alert
05/24/2024SNSEBuy Now
Sensei Biotherapeutics
$8.28-39.61%$5 → $5ReiteratesOverweight → OverweightGet Alert
05/14/2024DCTHBuy Now
Delcath Systems
$9.96151% → $25Initiates → OverweightGet Alert
05/14/2024BPMCBuy Now
Blueprint Medicines
→ $140Initiates → OverweightGet Alert
05/14/2024ATNMBuy Now
Actinium Pharma
$1.601462.5% → $25Initiates → OverweightGet Alert
05/14/2024EXELBuy Now
Exelixis
$41.98-45.21% → $23Initiates → Equal-WeightGet Alert
05/14/2024INOBuy Now
Inovio Pharmaceuticals
$2.55684.31% → $20Initiates → OverweightGet Alert
05/14/2024NRIXBuy Now
Nurix Therapeutics
$18.547.87% → $20Initiates → OverweightGet Alert
05/14/2024SNSEBuy Now
Sensei Biotherapeutics
$8.28-39.61% → $5Initiates → OverweightGet Alert
05/14/2024ELEVBuy Now
Elevation Oncology
→ $8Initiates → OverweightGet Alert